PAIN RELIEF FOLLOWING [APAROSCOPIC CHOLECYSTECTOMY
Not Applicable
Completed
- Conditions
- Health Condition 1: K819- Cholecystitis, unspecified
- Registration Number
- CTRI/2021/06/034068
- Lead Sponsor
- DNB Resident Dissertation No financial support
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
PATIENTS WHO ARE ASA CLASS 1 OR 2 UNDERGOING ELECTIVE LAPROSCOPIC SURGERY
BMI -18 TO 30
Exclusion Criteria
PATIENT WITH ECG SHOWING CONDUCTION ABNORMALITIES
PREGNANT AND BREASTFEEDING
PATIENT ON BETA BLOCKERS
PATIENT WITH CHRONIC PAIN ON OPIOIDS AND OTHER ANALGESICS
HISTORY OF ALLERGY TO STUDY DRUGS
SURGERY DURATIONS MORE THAN THREE HOURS
CONVERSION TO OPEN PROCEDURE
EMERGENCY CHOLYCYSTECTOMY
PATIENTS REQUIRING COMMON BILE DUCT EXPLORATIO
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the <br/ ><br>1.duration of analgesia after intraperitoneal instillation of ropivacaine with and without magnesium sulphate, <br/ ><br>2.Mean pain scores during 24 hour , <br/ ><br>3.total doses of rescue analgesics in each groups <br/ ><br>4.type of pain.Timepoint: baseline,1 hour,2hour.6 hour,12 hour,24 hour
- Secondary Outcome Measures
Name Time Method Secondary objective <br/ ><br>To study the post instillation hemodynamic changes in terms of heart rate(HR), systolic blood pressure(SBP), diastolic blood pressure(DBP), Oxygen saturation (SpO2), End Tidal Co2 (EtCO2) and postoperative nausea and vomiting(PONV)Timepoint: baseline,and every 2 hours for 24 hour.